Select Medical Holdings Co. (NYSE:SEM) Shares Sold by Nisa Investment Advisors LLC

Nisa Investment Advisors LLC lessened its holdings in Select Medical Holdings Co. (NYSE:SEMFree Report) by 45.9% in the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 2,380 shares of the health services provider’s stock after selling 2,019 shares during the quarter. Nisa Investment Advisors LLC’s holdings in Select Medical were worth $56,000 at the end of the most recent reporting period.

Other institutional investors have also added to or reduced their stakes in the company. Price T Rowe Associates Inc. MD raised its stake in shares of Select Medical by 6.0% in the fourth quarter. Price T Rowe Associates Inc. MD now owns 20,617,462 shares of the health services provider’s stock worth $511,932,000 after purchasing an additional 1,170,674 shares during the last quarter. Norges Bank purchased a new position in shares of Select Medical in the fourth quarter worth about $24,027,000. BlackRock Inc. raised its stake in shares of Select Medical by 4.3% in the first quarter. BlackRock Inc. now owns 18,575,139 shares of the health services provider’s stock worth $445,617,000 after purchasing an additional 762,219 shares during the last quarter. Deutsche Bank AG raised its stake in shares of Select Medical by 1,015.2% in the third quarter. Deutsche Bank AG now owns 553,306 shares of the health services provider’s stock worth $13,982,000 after purchasing an additional 503,692 shares during the last quarter. Finally, Goldman Sachs Group Inc. raised its stake in shares of Select Medical by 59.4% in the second quarter. Goldman Sachs Group Inc. now owns 844,997 shares of the health services provider’s stock worth $26,922,000 after purchasing an additional 314,890 shares during the last quarter. Institutional investors and hedge funds own 89.48% of the company’s stock.

Select Medical Stock Up 2.4 %

Shares of SEM stock opened at $27.06 on Monday. The stock has a 50 day moving average of $28.16 and a 200 day moving average of $25.64. The company has a current ratio of 1.01, a quick ratio of 1.01 and a debt-to-equity ratio of 2.32. The stock has a market cap of $3.47 billion, a P/E ratio of 14.17, a P/E/G ratio of 1.06 and a beta of 1.37. Select Medical Holdings Co. has a twelve month low of $21.28 and a twelve month high of $33.51.

Select Medical (NYSE:SEMGet Free Report) last posted its quarterly earnings data on Friday, February 23rd. The health services provider reported $0.36 EPS for the quarter, beating analysts’ consensus estimates of $0.31 by $0.05. The business had revenue of $1.66 billion during the quarter, compared to analysts’ expectations of $1.64 billion. Select Medical had a return on equity of 16.93% and a net margin of 3.65%. The business’s revenue was up 4.9% compared to the same quarter last year. During the same period in the previous year, the business earned $0.22 earnings per share. As a group, sell-side analysts expect that Select Medical Holdings Co. will post 2.03 EPS for the current year.

Select Medical Announces Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Wednesday, March 13th. Stockholders of record on Friday, March 1st were given a $0.125 dividend. This represents a $0.50 dividend on an annualized basis and a dividend yield of 1.85%. The ex-dividend date of this dividend was Thursday, February 29th. Select Medical’s dividend payout ratio (DPR) is presently 26.18%.

Analyst Upgrades and Downgrades

SEM has been the subject of several research analyst reports. StockNews.com upgraded Select Medical from a “hold” rating to a “buy” rating in a research note on Friday, March 22nd. Benchmark reiterated a “buy” rating and set a $39.00 price target on shares of Select Medical in a research report on Friday, April 12th. Two research analysts have rated the stock with a hold rating and three have given a buy rating to the company’s stock. Based on data from MarketBeat, Select Medical presently has a consensus rating of “Moderate Buy” and a consensus target price of $34.40.

Get Our Latest Stock Report on Select Medical

Insider Activity

In other news, Chairman Robert A. Ortenzio sold 50,000 shares of the business’s stock in a transaction that occurred on Monday, April 8th. The stock was sold at an average price of $29.90, for a total value of $1,495,000.00. Following the completion of the sale, the chairman now directly owns 6,689,668 shares in the company, valued at $200,021,073.20. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Company insiders own 19.14% of the company’s stock.

Select Medical Company Profile

(Free Report)

Select Medical Holdings Corporation, through its subsidiaries, operates critical illness recovery hospitals, rehabilitation hospitals, outpatient rehabilitation clinics, and occupational health centers in the United States. It operates in four segments: Critical Illness Recovery Hospital, Rehabilitation Hospital, Outpatient Rehabilitation, and Concentra.

Read More

Want to see what other hedge funds are holding SEM? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Select Medical Holdings Co. (NYSE:SEMFree Report).

Institutional Ownership by Quarter for Select Medical (NYSE:SEM)

Receive News & Ratings for Select Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Select Medical and related companies with MarketBeat.com's FREE daily email newsletter.